SELEGILINE TRANSDERMAL SYSTEM TREATMENT OF HIV ASSOCIATED COGNITIVE IMPAIRMENT

Project: Research project

Project Details

Description

To examine the safety and tolerability of the Selegiline Transdermal System (STS) in HIV-seropositive patients with mild to moderate cognitive impairment. To examine the benefits of the Selegiline Transdermal System (STS) on cognitive function.
StatusFinished
Effective start/end date10/1/979/30/99

Funding

  • National Center for Research Resources

ASJC Scopus Subject Areas

  • Clinical Neurology
  • Neurology
  • Infectious Diseases

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.